{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:13:06Z","timestamp":1759335186162},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1992,6,1]],"date-time":"1992-06-01T00:00:00Z","timestamp":707356800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[1992,6]]},"DOI":"10.1007\/bf00164573","type":"journal-article","created":{"date-parts":[[2004,11,2]],"date-time":"2004-11-02T15:17:38Z","timestamp":1099408658000},"page":"611-618","source":"Crossref","is-referenced-by-count":27,"title":["A muscarinic receptor different from the M1, M2, M3 and M4 subtypes mediates the contraction of the rabbit iris sphincter"],"prefix":"10.1007","volume":"345","author":[{"given":"I. T.","family":"Bognar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Altes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Beinhauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Fuder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"48","volume":"14","author":"O Arunlakshana","year":"1959","unstructured":"Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48?58","journal-title":"Br J Pharmacol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0014-2999(89)90195-7","volume":"163","author":"IT Bognar","year":"1989","unstructured":"Bognar IT, Baumann B, Dammann F, Knoll B, Meincke M, Pallas S, Fuder H (1989) M2 muscarinic receptors on the iris sphincter muscle differ from those on iris noradrenergic nerves. Eur J Pharmacol 163:263?274","journal-title":"Eur J Pharmacol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0014-2999(91)90096-9","volume":"192","author":"C Bolden","year":"1991","unstructured":"Bolden C, Cusack B, Richelson E (1991) Clozapine is a potent and selective muscarinic antagonist at the five cloned human muscarinic acetylcholine receptors expressed in CHO-K1 cells. Eur J Pharmacol 192:205?206","journal-title":"Eur J Pharmacol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0166-2236(89)90054-4","volume":"12","author":"TI Bonner","year":"1989","unstructured":"Bonner TI (1989) The molecular basis of muscarinic receptor diversity. Trends Neurosci 12:148?151","journal-title":"Trends Neurosci"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1126\/science.3037705","volume":"237","author":"TI Bonner","year":"1987","unstructured":"Bonner TI, Buckley NJ, Young AC, Brann MR (1987) Identification of a family of muscarinic acetylcholine receptor genes. Science 237:527?532","journal-title":"Science"},{"key":"CR6","first-page":"469","volume":"35","author":"NJ Buckley","year":"1989","unstructured":"Buckley NJ, Bonner TI, Buckley CM, Brann MR (1989) Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol Pharmacol 35:469?476","journal-title":"Mol Pharmacol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0014-2999(89)90846-7","volume":"161","author":"HN Doods","year":"1989","unstructured":"Doods HN, Mayer N (1989) UH-AH 37, an ileal-selective muscarinic antagonist that does not discriminate between M2 and M3 binding sites. Eur J Pharmacol 161:215?218","journal-title":"Eur J Pharmacol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0014-2999(91)90081-Z","volume":"192","author":"H Doods","year":"1991","unstructured":"Doods H, Entzeroth M, Mayer N (1991) Cardioselectivity of AQ-RA 741, a novel tricyclic antimuscarinic drug. Eur J Pharmacol 192:147?152","journal-title":"Eur J Pharmacol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/BF00169439","volume":"342","author":"F D\u00f6rje","year":"1990","unstructured":"D\u00f6rje F, Friebe T, Tacke R, Mutschler E, Lambrecht G (1990) Novel pharmacological profile of muscarinic receptors mediating contraction of the guinea-pig uterus. Naunyn-Schmiedeberg's Arch Pharmacol 342:284?289","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR10","first-page":"727","volume":"256","author":"F D\u00f6rje","year":"1991","unstructured":"D\u00f6rje F, Wess J, Lambrecht G, Tacke R, Mutschler E, Brann MR (1991) Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J Pharmacol Exp Ther 256:727?733","journal-title":"J Pharmacol Exp Ther"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1476-5381.1989.tb11843.x","volume":"96","author":"RM Eglen","year":"1989","unstructured":"Eglen RM, Michel AD, Whiting RL (1989) Characterization of the muscarinic receptor subtype mediating contractions of the guinea-pig uterus. Br J Pharmacol 96:497?499","journal-title":"Br J Pharmacol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1476-5381.1990.tb12983.x","volume":"99","author":"RM Eglen","year":"1990","unstructured":"Eglen RM, Michel AD, Montgomery WW, Kunysz EA, Machado CA, Whiting RL (1990) The interaction of parafluorohexahydrosiladiphenidol at muscarinic receptors in vitro. Br J Pharmacol 99:637?642","journal-title":"Br J Pharmacol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0014-2999(88)90801-1","volume":"151","author":"M Eltze","year":"1988","unstructured":"Eltze M (1988) Muscarinic M1- and M2-receptors mediating opposite effects on neuromuscular transmission in rabbit vas deferens. Eur J Pharmacol 151:205?221","journal-title":"Eur J Pharmacol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1476-5381.1990.tb12949.x","volume":"99","author":"R Feifel","year":"1990","unstructured":"Feifel R, Wagner-R\u00f6der M, Strohmann C, Tacke R, Waelbroeck M, Christophe J, Mutschler E, Lambrecht G (1990) Stereoselective inhibition of muscarinic receptor subtypes by the enantiomers of hexahydro-difenidol and acetylenic analogues. Br J Pharmacol 99:455?460","journal-title":"Br J Pharmacol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/BF00717733","volume":"340","author":"H Fuder","year":"1989","unstructured":"Fuder H, Sch\u00f6pf J, Unckell J, Wesner MTh, Melchiorre C, Tacke R, Mutschler E, Lambrecht G (1989) Different muscarine receptors mediate the prejunctional inhibition of [3H]-noradrenaline release in rat or guinea-pig iris and the contraction of the rabbit iris sphincter muscle. Naunyn-Schmiedeberg's Arch Pharmacol 340:597?604","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR16","first-page":"283","volume-title":"Handb Exp Pharmacol, vol 33. Catecholamines","author":"RF Furchgott","year":"1972","unstructured":"Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blaschko H, Muscholl E (eds) Handb Exp Pharmacol, vol 33. Catecholamines. Springer, Berlin Heidelberg New York, pp 283?335"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1146\/annurev.pa.30.040190.003221","volume":"30","author":"EC Hulme","year":"1990","unstructured":"Hulme EC, Birdsall NJM, Buckley NJ (1990) Muscarinic receptor subtypes. Ann Rev Pharmacol Toxicol 30:633?673","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(84)90492-8","volume":"103","author":"H Kilbinger","year":"1984","unstructured":"Kilbinger H, Halim S, Lambrecht G, Weiler W, Wessler I (1984) Comparison of affinities of muscarinic antagonists to pre- and postjunctional receptors in the guinea-pig ileum. Eur J Pharmacol 103:313?320","journal-title":"Eur J Pharmacol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0014-2999(88)90417-7","volume":"155","author":"G Lambrecht","year":"1988","unstructured":"Lambrecht G, Feifel R, Moser U, Aasen AJ, Waelbroeck M, Christophe J, Mutschler E (1988a) Stereoselectivity of the enantiomers of trihexyphenidyl and its methiodide at muscarinic receptor subtypes. Eur J Pharmacol 155:167?170","journal-title":"Eur J Pharmacol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0014-2999(88)90856-4","volume":"152","author":"G Lambrecht","year":"1988","unstructured":"Lambrecht G, Feifel R, Forth B, Strohmann C, Tacke R, Mutschler E (1988b) p-Fluoro-hexahydro-sila-difenidol: the first M2\u00df-selective muscarinic antagonist. Eur J Pharmacol 152:193?194","journal-title":"Eur J Pharmacol"},{"key":"CR21","first-page":"805","volume":"38","author":"S Lazareno","year":"1990","unstructured":"Lazareno S, Buckley NJ, Roberts FF (1990) Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108?15 cells. Mol Pharmacol 38:805?815","journal-title":"Mol Pharmacol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"PL55","DOI":"10.1016\/0024-3205(90)90204-5","volume":"47","author":"R Micheletti","year":"1990","unstructured":"Micheletti R, Schiavone A, Angelici O, Durand P, Giudici L, Cereda E, Donetti A (1990) Affinity profile of the novel muscarinic antagonist, guanylpirenzepine. Life Sci 47:PL55?58","journal-title":"Life Sci"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0028-3908(91)90016-5","volume":"30","author":"R Neeper","year":"1991","unstructured":"Neeper R, Richelson E, Nelson A (1991) Neuroleptic binding to muscarinic M2 receptors of normal human heart in vitro and comparison with binding to M1 and dopamine D2 receptors in brain. Neuropharmacology 30:527?529","journal-title":"Neuropharmacology"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/j.1476-5381.1991.tb09827.x","volume":"103","author":"EK Pedder","year":"1991","unstructured":"Pedder EK, Eveleigh P, Poyner D, Hulme EC, Birdsall NJM (1991) Modulation of the structure-binding relationships of antagonists for muscarinic acetylcholine receptor subtypes. Br J Pharmacol 103:1561?1567","journal-title":"Br J Pharmacol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.3107123","volume":"236","author":"EG Peralta","year":"1987","unstructured":"Peralta EG, Winslow JW, Peterson GL, Smith DH, Ashkenazi A, Ramachandran J, Schimerlik MI, Capon DJ (1987) Primary structure and biochemical properties of an M2 muscarinic receptor. Science 236:600?605","journal-title":"Science"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1476-5381.1990.tb13002.x","volume":"99","author":"MH Richards","year":"1990","unstructured":"Richards MH (1990) Rat hippocampal muscarinic autoreceptors are similar to the M2 (cardiac) subtype: comparison with hippocampal M1, atrial M2 and ileal M3 receptors. Br J Pharmacol 99:753?761","journal-title":"Br J Pharmacol"},{"key":"CR27","first-page":"267","volume":"38","author":"M Waelbroeck","year":"1990","unstructured":"Waelbroeck M, Tastenoy M, Camus J, Christophe J (1990) Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain. Mol Pharmacol 38:267?273","journal-title":"Mol Pharmacol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1476-5381.1991.tb12161.x","volume":"102","author":"J Wess","year":"1991","unstructured":"Wess J, Lambrecht G, Mutschler E, Brann MR, D\u00f6rje F (1991) Selectivity profile of the novel muscarinic antagonist UH-AH 37 determined by the use of cloned receptors and isolated tissue preparations. Br J Pharmacol 102:246?250","journal-title":"Br J Pharmacol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00164573.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00164573\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00164573","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T16:31:18Z","timestamp":1554741078000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00164573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1992,6]]}},"alternative-id":["BF00164573"],"URL":"https:\/\/doi.org\/10.1007\/bf00164573","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,6]]}}}